Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-07-13
1997-09-09
Geist, Gary
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514405, 514551, 514564, A61K 31415
Patent
active
056657579
ABSTRACT:
A method of treating anxiety in a warm blooded animal by administering an anti-anxiety effective amount of a nitric oxide synthase inhibitor, and compositions containing the same.
REFERENCES:
patent: 5216025 (1993-06-01), Gross et al.
patent: 5246970 (1993-09-01), Williamson et al.
patent: 5246971 (1993-09-01), Williamson et al.
patent: 5286739 (1994-02-01), Killbourn et al.
Haefely, Eur. Neuropsychopharmacol., vol. 1, 89-95 (1991).
Perregaard et al., Curr. Opin. Ther. Pat., vol. 3, 101-128 (1993).
Rees et al., Br. J. Pharmacol., vol. 101, pp. 746-752 (1990).
Moore et al., Br. J. Pharmacol, vol. 110, pp. 219-224 (1993).
Moore et al., Br. J. Pharmacol, vol. 108, pp. 296-297 (1993).
Lowenstein et al., Cell, vol. 70, pp. 705-707 (1992).
Meller et al., Pain, vol. 52, pp. 127-136 (1993).
Feldman et al., C&EN, pp. 26-38 (Dec. 1993).
Feldman et al. Chemtracts--Organic Chemistry, 5 pp. 217-221 (1992).
Life Sciences, vol. 51, No. 25, Quock et al., "Possible Involvement of Nitric Oxide in Chlordiazepoxide-Induced Anxiolysis in Mice", 1992, pp. PL-255-260.
Pharmacology Biochemistry and Behavior, vol. 48, No. 3, Caton et al., "Involvement of Nitric Oxide in Nitrous Oxide Anxiolysis in Elevated Plus-Maze", 1994, pp. 689-692.
Perregaard et al., "Recent Developments in Anxiolytics", Jan. 1993, Carr. Opin. Ther. Pat., vol. 3, pp. 111-112.
Rees et al., "Characterization of Three Inhibitors of Endothelial Nitric Oxide Synthase in Vitro and in Vivo", 1990, Br. J. Pharmacol., 101 pp. 746-751.
Moore et al., "Characterization of the Novel Nitric Oxide Synthase Inhibitor 7-nitro Indazole and Related Indazoles: Antinoceptive and Cardiovascular Effects", Br. J. Pharmacol. vol. 110 pp. 219-224.
Dunn Robert W.
La Marca Suzanne
Dunn Robert W.
Geist Gary
Williams Rosalynd
LandOfFree
Method for treating anxiety does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating anxiety, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating anxiety will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-70527